MedPath

determining the effect of magnesium,vitamin b6 and b6-magnesium combination on premenstrual syndrome in the affected persons that going to medical health centers of isfahan university

Phase 2
Conditions
premenstrual syndrome.
Premenstrual tension syndrome
Registration Number
IRCT201106216854N1
Lead Sponsor
Vice chancellor for research,Isfahan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
170
Inclusion Criteria

Inclusion criterial: The study population will be women of 45-15 referred to the selected health centers; who were affected by the PMS according to the criteria of American Psychiatry Association; and also met the inclusion criteria; being 45-15 years old; having regular menstrual cycle; not being affected by depression or anxiety; not having an acute or chronic disease; not taking medicines or supplements; and not taking regular exercise)

exclusion criterial: will be pregnancy; willingness to use hormonal contraceptive methods or taking hormonal treatment; not taking the drug or not filling out the forms regularly; and unwillingness to continue the treatment

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Premenstrual syndrome severity. Timepoint: 2 month before and 2 month after intervention. Method of measurement: questionnaire.
Secondary Outcome Measures
NameTimeMethod
. Timepoint: . Method of measurement: .
© Copyright 2025. All Rights Reserved by MedPath